Immuron appoints Gary S. Jacob as CEO

Immuron Limited, an Australian-based microbiome biopharmaceutical company focused on developing and commercializing oral...

November 20, 2018 | Tuesday | News
BVT successfully restores vision with its bionic eye

Bionic Vision Technologies Pty Ltd (BVT) announced medical researchers had successfully restored a sense of vision ...

November 19, 2018 | Monday | News
Five hospitals recognized at 6th HIMSS-Elsevier Digital Healthcare Awards

Singapore – Elsevier, the information analytics business specializing in science and health, and HIMSS Asia Pacifi...

November 8, 2018 | Thursday | News
Enesi Pharma, Sementis enter into R&D collaboration

UK based Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine ...

November 5, 2018 | Monday | News
Flagship life sciences conference demonstrates strength and value of sector

Singapore - The AusBiotech 2018 annual national three-day conference concluded in Brisbane after attracting over 1,000 d...

November 2, 2018 | Friday | News
AusBiotech, J&J announce Innovation Industry Excellence Awards

Singapore - The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards were announced at the AusBiot...

November 1, 2018 | Thursday | News
Novotech, CNS to expand CRO services to biopharma across APAC

Singapore - Novotech the largest Asia-Pacific-based CRO has acquired Australasian specialist CRO Clinical Network Servic...

October 17, 2018 | Wednesday | News
New technology to revolutionise healthcare

A team at Swansea University Medical School has developed a technology that enables the secure storage and sharing of la...

October 17, 2018 | Wednesday | News
Resident Doctor Mario Pennisi joins Elo-Australia

Elo Life Systems Inc. has announced that Mario G. Pennisi joined Elo Life Systems as a Resident Director of its Australi...

October 11, 2018 | Thursday | News
Alphamab starts phase I clinical trial in Australia

Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of ...

October 11, 2018 | Thursday | News
MGC Pharma receives TGA approval to market epilepsy drug in Australia

Australia's MGC Pharmaceuticals is pleased to announce the receipt of formal authorisation for the availability of its p...

October 11, 2018 | Thursday | News
One-third unplanned pregnancies aborted in Australia, says a survey

One in three unwanted pregnancies end in abortion, if recent research undertaken in Australia is any indication. The re...

October 8, 2018 | Monday | News
RMIT, Atmo sign licence agreement for gut sensors

RMIT University in Australia has signed a commercial licence agreement with start-up Atmo Biosciences for ingestible sen...

October 3, 2018 | Wednesday | News
Invion spin-off selects leading CRO for nadolol development

Singapore - Chronic Airway Therapeutics (CAT), a proposed spin-off from Invion Limited, has selected leading Chinese con...

September 27, 2018 | Thursday | News
Virtus appoints new non-executive director

Singapore – Virtus Health announces the appointment of Shane Solomon to its Board as a Non-Executive Director. Sol...

September 27, 2018 | Thursday | News
Sun Pharma announces Australian TGA approval of ILUMYA

India's Sun Pharmaceutical recently announced that Sun Pharma has received the Australian Therapeutic Goods Administrati...

September 25, 2018 | Tuesday | News
Minomic announces demerger of Glytherix

Minomic International Ltd has announced that it received strong shareholder approval to approve the demerger of its...

September 25, 2018 | Tuesday | News
Immutep collaborates with Merck, Pfizer for Efti

Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...

September 25, 2018 | Tuesday | News